AU2018338451A1 - Immunoassays for detection of RAN proteins - Google Patents

Immunoassays for detection of RAN proteins Download PDF

Info

Publication number
AU2018338451A1
AU2018338451A1 AU2018338451A AU2018338451A AU2018338451A1 AU 2018338451 A1 AU2018338451 A1 AU 2018338451A1 AU 2018338451 A AU2018338451 A AU 2018338451A AU 2018338451 A AU2018338451 A AU 2018338451A AU 2018338451 A1 AU2018338451 A1 AU 2018338451A1
Authority
AU
Australia
Prior art keywords
ran
poly
subject
antibody
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018338451A
Other languages
English (en)
Inventor
Lien Nguyen
Laura Ranum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida Research Foundation Inc
Original Assignee
University of Florida Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida Research Foundation Inc filed Critical University of Florida Research Foundation Inc
Publication of AU2018338451A1 publication Critical patent/AU2018338451A1/en
Priority to AU2024219412A priority Critical patent/AU2024219412A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/76—Chemiluminescence; Bioluminescence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/30—Electrochemically active labels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plasma & Fusion (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AU2018338451A 2017-09-25 2018-09-25 Immunoassays for detection of RAN proteins Abandoned AU2018338451A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2024219412A AU2024219412A1 (en) 2017-09-25 2024-09-04 Immunoassays for detection of ran proteins

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762563009P 2017-09-25 2017-09-25
US62/563,009 2017-09-25
PCT/US2018/052745 WO2019060918A1 (en) 2017-09-25 2018-09-25 IMMUNOLOGICAL ASSAYS FOR DETECTION OF RAN PROTEINS

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2024219412A Division AU2024219412A1 (en) 2017-09-25 2024-09-04 Immunoassays for detection of ran proteins

Publications (1)

Publication Number Publication Date
AU2018338451A1 true AU2018338451A1 (en) 2020-04-02

Family

ID=65811531

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2018338451A Abandoned AU2018338451A1 (en) 2017-09-25 2018-09-25 Immunoassays for detection of RAN proteins
AU2024219412A Pending AU2024219412A1 (en) 2017-09-25 2024-09-04 Immunoassays for detection of ran proteins

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2024219412A Pending AU2024219412A1 (en) 2017-09-25 2024-09-04 Immunoassays for detection of ran proteins

Country Status (5)

Country Link
EP (1) EP3688020A4 (enExample)
JP (2) JP2020535448A (enExample)
AU (2) AU2018338451A1 (enExample)
CA (1) CA3075908A1 (enExample)
WO (1) WO2019060918A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2970884A4 (en) 2013-03-14 2016-11-02 Univ Florida DI-AMINO ACID-REINFORCED PROTEINS ASSOCIATED WITH ALS
WO2016196324A1 (en) 2015-05-29 2016-12-08 University Of Floridia Research Foundation, Inc. Methods for diagnosing huntington's disease
US10940161B2 (en) 2016-04-04 2021-03-09 University Of Florida Research Foundation, Incorporated Manipulation of EIF3 to modulate repeat associated non-ATG (RAN) translation
JP7526455B2 (ja) 2017-04-17 2024-08-01 ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． ＰＫＲおよびｅＩＦ２Ａ－Ｐ経路によるＲＡＮタンパク質翻訳の調節
JP7350337B2 (ja) 2017-09-26 2023-09-26 ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． 神経障害の処置においてｒａｎタンパク質レベルを低下させるためのメトホルミンおよびそのアナログの使用
US20220267776A1 (en) * 2019-07-05 2022-08-25 University Of Florida Research Foundation, Incorporated Methods for treating ran protein-associated neurological diseases
JP7620988B2 (ja) * 2019-09-20 2025-01-24 ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． 血清および組織ライセートからのｒａｎタンパク質に対する抗体の検出
US20240069039A1 (en) * 2019-10-10 2024-02-29 University Of Florida Research Foundation, Incorporated Ran proteins as biomarkers in cag/ctg expansion disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2082225E (pt) * 2006-09-20 2014-04-10 Univ Belfast Método para determinar se uma célula tumoral tem potencial invasivo e/ou metastático e agentes moduladores de transformação maligna
MX365235B (es) * 2010-11-30 2019-05-28 Chugai Pharmaceutical Co Ltd Molécula de unión a antígeno capaz de unir repetidamente a la pluralidad de moléculas de antígeno.
EP2970884A4 (en) * 2013-03-14 2016-11-02 Univ Florida DI-AMINO ACID-REINFORCED PROTEINS ASSOCIATED WITH ALS
CA2990161A1 (en) * 2014-08-13 2016-02-18 The Scripps Research Institute Treatment of c9ftd/als by targeting rna expanded repeat sequences
JP6508996B2 (ja) * 2015-03-24 2019-05-08 東ソー株式会社 β−ＡＮＰによる心不全の検出方法
AU2016333538B2 (en) * 2015-10-02 2022-03-31 Julius-Maximilians-Universität Würzburg GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers

Also Published As

Publication number Publication date
EP3688020A4 (en) 2021-07-14
EP3688020A1 (en) 2020-08-05
JP2020535448A (ja) 2020-12-03
AU2024219412A1 (en) 2024-09-26
CA3075908A1 (en) 2019-03-28
JP2023174663A (ja) 2023-12-08
US20200232925A1 (en) 2020-07-23
WO2019060918A8 (en) 2019-04-18
WO2019060918A1 (en) 2019-03-28

Similar Documents

Publication Publication Date Title
AU2024219412A1 (en) Immunoassays for detection of ran proteins
US8753892B2 (en) Phosphodiesterase 4D7 as prostate cancer marker
JP2011501741A (ja) がんの診断および治療のためのｔａｚ／ｗｗｔｒ１
WO2014208645A1 (ja) そう痒を伴う疾患に罹患した患者のｉｌ－３１アンタゴニストによる治療に対する応答を予測する方法
US20240069039A1 (en) Ran proteins as biomarkers in cag/ctg expansion disorders
JP2005510251A5 (enExample)
JP6240919B2 (ja) 加齢または筋萎縮の診断用バイオマーカー
US20160139149A1 (en) Chi3l1 for the detection and treatment of nonalcoholic steatohepatitis
KR20230081950A (ko) 갑상선 안병증의 진단을 위한 바이오마커 및 이의 용도
US12504380B2 (en) Immunoassays for detection of ran proteins
JP2006520588A (ja) 治療薬、予防薬、および診断薬
KR102583540B1 (ko) 퇴행성 뇌질환에서 zbtb16의 용도
CN111630185A (zh) 包含pmvk作为活性成分的用于诊断耐放射癌症或预测放射疗法预后的生物标志物组合物
EP2791686B1 (en) Tenascin-c and use thereof in rheumatoid arthritis
JP2016104716A (ja) 膵臓癌治療用のｃｄ９５シグナル伝達阻害化合物
US20240210407A1 (en) Compositions and methods for detecting and treating pathological fibroblast cells
CN111440870A (zh) CircZCCHC11及其翻译的肽段在肿瘤生长和转移预测、预后评估和治疗中的应用
JP5830329B2 (ja) 腎障害の新規マーカー
US20240280590A1 (en) Compositions and methods for facioscapulohumeral muscular dystrophy biomarker detection
CA2801162A1 (en) Diagnostic, screening and therapeutic applications of ocab-based tools
US7674578B2 (en) Methods of using sIP-10 to assess HCV clearance and/or response to interferon therapy
JP2025077049A (ja) Ｃａｒｄ１４を用いた治療、診断およびスクリーニング
WO2023041805A1 (en) Methods for improving the efficacy of hdac inhibitor therapy and predicting the response to treatment with hdac inhibitor
CN117794584A (zh) 包含msh2或msh6抑制剂作为有效成分的用于预防或治疗癌症的组合物
JPWO2006035702A1 (ja) Ｃペプチド特異的結合分子及びその用途

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted